There seems to be a lot of breakthroughs in the medical industry related to the immune system lately, and I'm so excited to hear about them! In fact, a recent article titled Adaptive Bio receives US patent for next generation immunosequencing field in Pharmabiz.com (an online pharmaceutical journal in India) stated the following:
"Adaptive Biotechnologies Corporation...has obtained a notice of allowance in US Patent Application Serial No. 12/794,507, titled “Method of Measuring Adaptive Immunity""
Adaptive Biotechnologies has apparently come up with a new way of sequencing the adaptive immune system (Killer T Cells and B Cells) to aid in a range of applications related to immune system dysfunction. This technology will help the medical industry make advancements in the monitoring and treatment of cancer and other immune (and auto-immune) diseases.
